Introduction to SVHC Roadmap to 2020
The "Roadmap for SVHC identification and implementation of REACH Risk Management measures from now to 2020" (called the SVHC Roadmap) gives an EU-wide commitment for having all relevant currently known substances of very high concern (SVHCs) included in the Candidate List by 2020. The objective of the SVHC Roadmap is to present a credible process to make sure this objective is achieved. The SVHC Roadmap outlines a methodology for working towards achieving this objective, with clear deliverables, planning and sharing of responsibilities.
SVHC Roadmap implementation plan
A plan has been developed on how to implement the SVHC Roadmap between now and 2020. The SVHC Roadmap implementation plan focuses on how the following work can be organised, coordinated and carried out:
- Screening to identify new substances of concern, and
- Analysing the risk management options (RMOs) appropriate to the particular substance of concern.
The implementation plan also gives an outline of how progress monitoring and communication towards stakeholders and the general public is foreseen.
Finding and analysing new substances for regulatory risk management
The SVHC Roadmap to 2020 anticipates the use of screening methods and regulatory management option analysis (RMOA) to identify the relevant substances of concern using information from the ECHA registration database, other REACH and CLP databases and additional relevant data.
The SVHC Roadmap to 2020 lists certain groups of substances to be covered by the implementation plan:
- Carcinogens, mutagens, reprotoxicants (Categories 1A/1B),
- Persistent, bioaccumulative and toxic (PBTs) or very persistent, very bioaccumulative (vPvBs),
- Endocrine disruptors (EDs), and
- Petroleum/coal stream substances that are CMRs or PBTs.
Each year, ECHA publishes a report on the progress of implementing the "SVHC Roadmap". The report(s), available in the links below, summarises the main achievements and activities carried out in the previous year and outline activities planned for the following year. The annual reports contain no substance specific information.